Publicité
Publicité

CTSO

CTSO logo

Cytosorbents Corp.

0.68
USD
Sponsorisé
0.00
+0.59%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

0.68

0.00
0.00%

CTSO Rapports sur les bénéfices

Ratio de surprise positive

CTSO a dépassé 21 des 40 dernières estimations.

53%

Prochain rapport

Date du prochain rapport
01 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.81M
/
-$0.04
Variation implicite de Q4 26 (Revenue/ EPS)
--
/
--
Variation implicite de Q4 24 (Revenue/ EPS)
+7.18%
/
-71.43%

Cytosorbents Corp. earnings per share and revenue

On 02 janv. 2026, CTSO reported earnings of -- USD per share (EPS) for Q4 26, -- the estimate of -0.01 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 11.26 million, with a --% difference. The market reacted with a +2.60% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analystes forecast an EPS of -0.04 USD, with revenue projected to reach 9.81 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Neogen Corp
Report Date
08 janv. 2026 Pour Q2 26
Estimation
$0.05
Actuel
$0.10
Surprise
+78.25%
logo
Tilray Brands, Inc. Common Stock
Report Date
08 janv. 2026 Pour Q2 26
Estimation
-$0.20
Actuel
-$0.41
Surprise
-100.98%
FAQ
For Q4 2026, Cytosorbents Corp. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved up 2.6%, changed from $0.64 before the earnings release to $0.66 the day after.
The next earning report is scheduled for 01 mars 2026.
Based on 5 analystes, Cytosorbents Corp. is expected to report EPS of -$0.04 and revenue of $9.81M for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité